At the University of Minnesota's heart lab, millions of dollars of tubing and wires and technology work to keep a living ...
Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...
How mission plus performance can lead to sustainable success.
In the latest trading session, Medtronic (MDT) closed at $90.01, marking a -0.89% move from the previous day. This change was narrower than the S&P 500's daily loss of 0.95%. Meanwhile, the Dow ...
Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its ...
Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare ...
The company will keep the systems on the market but is asking providers to check devices for visible cracks and return ...
Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A ...
Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...
In a report released today, Matthew O’Brien from Piper Sandler maintained a Hold rating on Medtronic (MDT – Research Report), with a price ...
In December, YNHH integrated the newly FDA-approved Medtronic VitalFlow ECMO System and first used it to transfer a patient ...